SynthesisThe European journal of health economics : HEPAC : health economics in prevention and care2014

Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique.

Bonny Parkinson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.